Science Explorer Interactive view Map
Company · Abingdon · United Kingdom

Oxford Biotherapeutics (United Kingdom)

oxfordbiotherapeutics.comROR OpenAlex
Research works
42
▼ 10% vs 2013–17
Citations
301
7.2 per fractional work
Top-10% rate
10.9%
record average 16.5%
Open access
42%
world 28%

Not ranked overall: Oxford Biotherapeutics (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.49× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 14.19× its world share, 2 worksImmunology and Micro…Neuroscience: 1.59× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.04× its world share, 0 worksPharmacology, Toxico…Engineering: 0.03× its world share, 0 worksEngineeringMaterials Science: 0.15× its world share, 0 worksMaterials ScienceHealth Professions: 0.82× its world share, 0 worksHealth ProfessionsMedicine: 2.93× its world share, 9 worksMedicineNursing: 1.10× its world share, 0 worksNursingArts and Humanities: 0.75× its world share, 0 worksArts and HumanitiesDecision Sciences: 0.83× its world share, 0 worksDecision SciencesSocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.2×. Every wedge is a field page.

Which keywords describe research at Oxford Biotherapeutics (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Immunotherapy, Cancer Immunotherapy, Gene Therapy, Tumor Regression, Tumor Microenvironment, Inflammation and Fc Receptors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation4▲ 41×3 topics
  2. Inflammation4▲ 3.8×17 topics
  3. Immunotherapy4▲ 13×10 topics
  4. Cancer Immunotherapy3▲ 56×3 topics
  5. Gene Therapy3▲ 29×3 topics
  6. Tumor Microenvironment3▲ 20×4 topics
  7. Tumor Regression3▲ 80×2 topics
  8. Fc Receptors3▲ 64×1 topic
  9. Therapeutic Antibodies3▲ 50×1 topic
  10. Cancer2▲ 3.4×11 topics
  11. Immunity2▲ 14×4 topics
  12. Innate Immunity2▲ 14×6 topics
  13. Pharmacology2▲ 15×3 topics
  14. Lymphoma2▲ 31×2 topics
  15. Monoclonal Antibody2▲ 64×2 topics
  16. AAV2▲ 68×1 topic
  17. Viral Vectors2▲ 68×1 topic
  18. Alzheimer's Disease2▲ 15×4 topics
  19. CAR T Cells2▲ 95×1 topic
  20. Chimeric Antigen Receptor2▲ 95×1 topic
  21. Immune Checkpoint Blockade2▲ 74×1 topic
  22. PD-1 and PD-L12▲ 74×1 topic
  23. Neurodegenerative Diseases2▲ 18×3 topics
  24. Chemotherapy2▲ 5.0×6 topics
  25. Antigen Presentation1▲ 33×2 topics
  26. Dendritic Cells1▲ 28×1 topic
  27. PET Imaging1▲ 16×3 topics
  28. Tumor Antigen1▲ 40×1 topic
  29. Tumor Targeting1▲ 26×3 topics
  30. Acetylcholinesterase1▲ 109×1 topic
  31. Allergic Diseases1▲ 40×1 topic
  32. Asthma1▲ 25×1 topic
  33. Breast Cancer1▲ 11×2 topics
  34. Cholinesterase Inhibitors1▲ 109×1 topic
  35. Drug Development1▲ 23×2 topics
  36. Pharmacokinetics1▲ 11×5 topics
  37. Arginine Deprivation1▲ 66×1 topic
  38. Bacterial Therapy1▲ 66×1 topic
  39. High-Throughput Analysis1▲ 62×1 topic
  40. Targeted Therapy1▲ 13×4 topics

Which research topics does Oxford Biotherapeutics (United Kingdom) publish most on?

By volume in 2022–2025: Virus-based gene therapy research, Asthma and respiratory diseases, Monoclonal and Polyclonal Antibodies Research and Immunotherapy and Immune Responses.

Virus-based gene therapy…1Virus-based gene therapy research: 1 fractional worksAsthma and respiratory d…1Asthma and respiratory diseases: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksCAR-T cell therapy research: 1 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksImmune Cell Function and…0Immune Cell Function and Interaction: 0 fractional worksT-cell and B-cell Immunology: 0 fractional worksCancer Research and Treatments: 0 fractional worksPediatric health and respiratory diseases: 0 fractional works
GeneticsPhysiologyRadiology, Nuclear Medicine and ImagingImmunology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Virus-based gene therapy research Genetics 1 works
  2. 2 Asthma and respiratory diseases Physiology 1 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Immunotherapy and Immune Responses Immunology 1 works
  5. 5 CAR-T cell therapy research Oncology 1 works
  6. 6 HER2/EGFR in Cancer Research Oncology 1 works
  7. 7 Immune Cell Function and Interaction Immunology 0 works
  8. 8 T-cell and B-cell Immunology Immunology 0 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 Pediatric health and respiratory diseases Emergency Medical Services 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.7%not open58.3%

World: 28% of research is openly available.

with international co-authors53.5%domestic only46.5%

World: 19% is written across borders.

How has Oxford Biotherapeutics (United Kingdom)'s research output changed?

Output in 2018–2022 was 10% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Abingdon

All research institutions in Abingdon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.